Endoscopy 2000; 32(9): 715-719
DOI: 10.1055/s-2000-9228
Review
Georg Thieme Verlag Stuttgart · New York

Photodynamic Therapy in Gastroenterology: Current Status in the Year 2000

H.C. Wolfsen
  • Dept. of Photodynamic Therapy and the Esophageal Disease Clinic, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Preview

Photodynamic therapy (PDT) involves the interaction between a photosensitizing agent and light, in the presence of oxygen, to produce photodamage to target tissue. While photodynamic therapy has been used since ancient times to treat dermatoses, it was not until the 1960s that porphyrin-based photosensitizers were first used for photodetection and phototherapy of malignancies. Thereafter, clinical experience accumulated slowly until the mid-1990s, when regulatory approval for PDT using porfimer sodium was granted in parts of North America, Europe, and Japan. This paper reviews recent clinical advances and discusses technological developments that may soon alter the way in which photodynamic therapy is used.

References

M.D. H. WolfsenC. 

Division of Gastroenterology and Hepatology Mayo Clinic

Director of Photodynamic Therapy

4500 San Pablo Road

Jacksonville, FL 32224

USA

Phone: + 1-904-953-7260

Email: pdt@mayo.edu